Betsy DeVos – Setting Her Sights on Success for all Children

Betsy DeVos was chosen as Secretary of Education amid much controversy. Critics claimed that DeVos had no experience in education; they claimed that she was nothing more than a rich philanthropist. Had those same critics actually looked over Mrs. DeVos’ body of work – in education – they would see that she has done more than enough to prepare herself for a role as a successful Secretary of Education. She truly has the welfare and success of children in mind.

Betsy and Dick DeVos Saw A Need

Betsy and Dick DeVos were active parents in their children’s school. Wanting nothing but the best for their children, they became interested in the Potter’s House Christian School, where they noticed many low-income parents scrimping and saving to send their children to a school with a safe, exciting learning environment. This spurred the couple to create a foundation that helped provide scholarships so that low-income families could send their children to the school of their choice. This also influenced Betsy’s ideas regarding school choice. Betsy would go on to serve as chairperson for other charities that support school choice.


Betsy’s Involvement in Politics

While critics said Betsy DeVos had no political experience, a little research proves that this could not be further from the truth. Two charities Mrs. DeVos worked with, Children First America and the American Education Reform Council, worked to promote vouchers and tax credits to enable parents to afford to send their children to the school of their choice. Mrs. DeVos was directly involved in the passage of Michigan’s first charter school bill in 1993, and they worked to change the state constitution to allow tax-credit scholarships or vouchers. While this was not successful, this didn’t stop Mrs. DeVos. She started the Great Lakes Education Project while also chairing the Michigan Republican Party. This new project sought to promote the incorporation of charter schools statewide. Upon the advice of friends, she decided that all the nation’s children could benefit from charter schools. Eventually, Mrs. DeVos would be the chairwoman of the American Federation for Children. Mrs. DeVos has seen success in Florida with major gains in Louisiana and Indiana.

Hope for Education – Hope for All

Because of the hard work Mr. and Mrs. DeVos have put into the nation’s children, over one million children now attend the school their family chose for them. Mr. and Mrs. DeVos actually opened their own charter school, and they have first-hand experience with the process. Betsy continues to serve as a board member of the Foundation for Excellence and mentors children through the Kids Hope USA program. Visit to know more about Betsy.

Yes, Betsy DeVos was a perfect choice for Secretary of Education. She brings over twenty years of experience to education reform. We all agree that America’s educational system is broken; Betsy and Dick DeVos have pioneered educational reform in Michigan. They continue to work so that all American children have the best education possible.

InnovaCare Health: Leaders Dr. Shinto and Penelope Kokkinides

Dr. Richard Shinto has been in the managed care industry for over 20 years. Much of his career has focused on clinical and operational healthcare. Currently, Dr. Shinto is President and CEO of InnovaCare, Inc. He’s also the CEO of InnovaCare’s Health Plans in Puerto Rico.

In Southern California, Dr. Shinto has medical tenure as a practicing internist and pulmonologist. He’s also written several healthcare and clinical medicine articles. He earned his medical degree from the State University of New York. He has two other degrees: an MBA from the University of Redlands and a BS from the University of California.

His first big job was as COO and Chief Medical Officer at Medical Pathways Management Company. In 1996, he joined MedPartners as Corporate VP of Medical Management. After leaving MedPartners, he joined NAMM and served as Chief Medical Officer. Eventually, he wound up at Aveta Inc., where he served as CEO until its sale in 2012.

Penelope Kokkinides is Chief Administrative Officer at InnovaCare, Inc. Kokkinides also have over 20 years of experience in the managed care industry. She, however, specializes in working with government programs, including Medicare and Medicaid. Visit for more info on Penelope Kokkinides.

Her acceptance of the Chief Administrative Officer position is her second time working for InnovaCare. Prior, she served as COO. She left InnovaCare to focus on her work at Aveta Inc. as COO and VP of Clinical Operations. Before joining InnovaCare the first time, Kokkinides was Executive VP and COO of Centerlight Healthcare.

Penelope Kokkinides studied and Binghamton University, where she earned her Bachelor’s degree in biological science and classical languages. She also holds a post-Master’s and a Master’s degree from Columbia University School of Public Health. She even attended New York University, where she earned her Master’s degree in social work.

Both professionals joined InnovaCare Health because they believe in bettering health care for everyone. InnovaCare is redefining healthcare management. Today’s healthcare environment is hectic and complex. InnovaCare provides numerous services that remove or weaken the obstacles that many face while trying to get quality medical care. Learn more about Penelope on Bizjournals.

Know more:

In order to redefine an entire industry, InnovaCare went back to the drawing board. Along with all their subsidiaries, InnovaCare is building new, sustainable managed care models. These models are more coordinated, cost-effective, innovative, and driven by quality. InnovaCare puts their patients’ health first and foremost.

Mikhail Blagosklonny on Anti-Aging Drugs

Many people believe that aging is brought about by consistent molecular damage with no means of prevention. Mikhail Blagosklonny who is a renowned scientist focusing on the study of aging and cancer gave a different account of this belief about aging. In the article, rejuvenating immunity aging is explained through hyperfunction theory. The theory holds that aging is simply a constant growth that is caused by signaling pathways which include Target of Rapamycin (TOR). The TOR models envisage that the rapamycin or any other rapalog has the capability to prevent diseases and treat aging in humans. Apparently so as to experience the full benefit from the rapamycin and other rapalogs, one needs to take the right doses and follow a regular schedule. Every theory faces acceptance, and some criticism and hyperfunction theory was not exceptional. However, in 2008, it was envisaged that those who opposed the theory by then, will take the TOR model for granted and this prediction came to happen.

A study was carried out on one of rapamycin analogs, Evirolimus (RAD001) and it was held that the analog is capable of improving immunity to the aging people. These were sensational news which said that the Novartis who were researching on ‘Fountain of Youth’ Drug might have found the drug that could help to delay the effects of an aging human being and also enhance their health. Nir Barzilai summarized the report saying that the research sets a standard stage to begin using drugs to target aging so as to improve every aspect of aging. He adds that the research is a turning point for many scientists. Visit ResearchGate to keep up to date with Mikhail’s latest work.

Looking into the history of rapamycin, it was in the year 2006 when Rapamune or Sirolimus which is a form of rapamycin, was approved to be used for clinical purposes. The drug was available, and apart from being believed to heal diseases such as cancer, autoimmunity, metabolic disorders and cardiovascular diseases, it was proven to heal diseases related to aging such as Alzheimer and osteoporosis. Rapamycin was expected to be rampantly used as an anti-aging drug to delay senescence and prevent illnesses as well. The drug is also recommended to be taken by transplant patients for some time so as to enhance their health. It is believed that rapamycin is capable of changing immunity of aging person from ‘aged-type’ to ‘infant type’ because instead of suppressing immunity, it eradicates hyper-immunity.

About Mikhail Blagosklonny

Mikhail Blagosklonny is a prominent scientist who specializes in the study of cancer and aging. He is currently an oncology professor at Roswell Park Cancer Institute where he has been serving since the year 2009. Mikhail Blagosklonny gained his MD in internal medicine and a Ph.D. in Experimental Medicine and Cardiology from First Pavlov State Medical University in St. Petersburg. In the year 2002, he joined New York Medical College where he became an associate professor of medicine and later he went to Ordway Research Institute serving as a senior scientist. Mikhail Blagosklonny managed to attain adequate experience from the different places he had worked for, and this made him a prominent professor who is mostly interested in anti-aging drugs, cancer, Biogerontology and cancer-related therapies. Check Mikhail’s profile in LinkedIn.